Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-06-27
1997-01-21
Killos, Paul J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514274, A61K 31505
Patent
active
055959792
ABSTRACT:
The present invention relates to a method of treating a patient afflicted with a neoplastic disease state comprising the administration thereto of an effective antineoplastic amount of ionizing or nonionizing radiation, or an effective antineoplastic amount of a DNA-reactive chemotherapeutic agent in conjunctive therapy with an effective sensitizing amount of a compound of formula (I).
REFERENCES:
patent: 3472837 (1969-10-01), Verheyden et al.
patent: 4199574 (1980-04-01), Schaeffer
patent: 4334063 (1982-06-01), Spry
patent: 4894364 (1990-01-01), Greer
patent: 5026835 (1991-06-01), Ueda et al.
patent: 5047520 (1991-09-01), Matsuda et al.
patent: 5378693 (1995-01-01), McCarthy et al.
patent: 5401726 (1995-03-01), Ueda et al.
patent: 5508393 (1996-04-01), McCarthy et al.
Matsuda et al, "Alkyl Addition Reaction of Pyrimidine, 2'-Ketonucleosides: Syntheses of 2'-Branched-Chain Sugar Pyrimidine Nucleosides" Chem. Pharm. Bull. 36(3) 945-953 (1988).
Hansske et al., "Nucleic Acid Related Compounds. 43. A Convenient Procedure for the Synthesis fo 2' and 3'-Ketonucleosides" Tetrahedron Letters, vol. 24, No. 15, pp. 1589-1592, (1983).
Hansske et al., "2'and 3'-Ketonucleosides and their Arabino and Xylo Reduction Products" Tetrahedron vol. 40, No. 1, pp. 125-135, (1984).
Takenuki, et al., Journal of Medicinal Chemistry 31:1063-1064 (1988).
Ueda et al, "Synthesis of 2'-Deoxy-8,2'-ethanoadenosine and 3'-Deoxy-8,3'-ethanoadenosine (Nucleosides and Nucleotides. LXIV)" Chem. Pharm. Bull. 34(1) pp. 15-23, (1986).
McCarthy et al, J. Am. Chem. Soc. 1991, pp. 7439-7440.
Carter et al., Chemotherapy of Cancer, second edition, pp. 76-83 (1989).
Sunkara et al, Proceedings 83 Annual Meeting of the American Association for Cancer Research, vol. 33, No. 3088, Mar. 1992, p. 517.
Kobayasky et al., Pharmaceutical Research, vol. 4, Jul. 4, 1984, pp. 181-183.
Sunkara et al, "Cytotoxicity of Methylglyoxal Bis(guanylhydrazone) in Combination with .alpha.-Diflurormethylornithine Against HeLa Cells and Mouse L1210 Leukemia", JNCl, vol. 70, No. 3, pp. 505-509 Mar. 1983.
Katritzky, et al, Comprehensive Heterocyclic Chemistry, vol. 5, pp. 603 & 989 (1986).
Ueda et al, "Synthesis of 2'(R)-Substituted Neplanocin A's (Nucleosides and Nucleotides XXXVII)", Chem. Pharm. Bull. 29(2) pp. 597-600 (1981).
Ferrier, Adv. Carbohydrate Chem. 24:250-251 (1969).
De Clercq, "S-Adenosylhomocysteine Hydrolase Inhibitors as Broad Spectrum Antiviral Agents" Biochemical Pharmacology, vol. 36, No. 1, pp. 2567-2575 (1l987).
McCarthy et al., J. Am. Chem. Soc. 1991, 113, 7439-7440.
Bitonti A J. et al. Breast Cancer Research and Treatment, vol. 27, No. 1/2. 1993 Bitonti et al.
Rockwell et al, Oncology Research vol. 4, No. 4/5 1992, pp. 151-155.
Snyder, Oncology Research, vol. 6, Nos. 4/5, pp. 177-182, 1994.
Patel, et al, The Cancer Journal, vol. 5, N. 5 Sep. Oct. 1992.
Boudreaux William R.
Frazier Barbara S.
Killos Paul J.
Merrell Pharmaceuticals Inc.
LandOfFree
Method of treating a neoplastic disease state by conjunctive the does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating a neoplastic disease state by conjunctive the, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating a neoplastic disease state by conjunctive the will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2324277